These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1175124)

  • 1. A controlled study in the use of combined drug therapy for metastatic breast cancer.
    Brunner KW; Sonntag RW; Martz G; Senn HJ; Obrecht P; Alberto P
    Cancer; 1975 Oct; 36(4):1208-19. PubMed ID: 1175124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 5. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract]   [Full Text] [Related]  

  • 6. Outpatient chemotherapy of advanced breast cancer in a community setting: a five-drug regimen.
    West JH
    South Med J; 1976 Jun; 69(6):741-6. PubMed ID: 935904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemo- and hormonal therapy in advanced breast cancer.
    Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
    Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatic metastases from breast cancer.
    Bugarski M; Vuletić L; Boberić J; Milosavljević A; Dilparić S; Tomin R; Naumović P
    Clin Oncol; 1978 Jun; 4(2):167-71. PubMed ID: 668248
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy in breast cancer: a randomized study of 4 versus 5 drugs.
    Ramirez G; Klotz J; Strawitz JG; Wilson WL; Cornell GN; Madden RE; Minton JP
    Oncology; 1975; 32(3-4):101-8. PubMed ID: 1221326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukemia complicating metastatic breast cancer.
    Davis HL; Prout MN; McKenna PJ; Cole DR; Korbitz BC
    Cancer; 1973 Mar; 31(3):543-6. PubMed ID: 4511910
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M; Fernholz HJ; Frik W
    Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
    Mattsson W; Arwidi A; von Eyben F; Lindholm CE
    Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for breast cancer.
    Allegra JC; Lippman ME
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM; Bruntsch U; Schmidt CG
    Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.